Improvement of Quality of Response with Ibrutinib Plus Bendamustine/Rituximab Vs Placebo Plus Bendamustine/Rituximab for Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

被引：0

作者：

Cramer, Paula ^{[1
]}

Chanan-Khan, Asher ^{[2
]}

Fraser, Graeme ^{[3
]}

Demirkan, Fatih ^{[4
]}

Silva, Rodrigo Santucci ^{[5
]}

Pylypenko, Halyna ^{[6
]}

Grosicki, Sebastian ^{[7
,8
]}

Janssens, Ann ^{[9
]}

Goy, Andre ^{[10
]}

Mayer, Jiri ^{[11
,12
]}

Dilhuydy, Marie Sarah ^{[13
]}

Loscertales, Javier ^{[14
]}

Bartlett, Nancy L. ^{[15
]}

Avigdor, Abraham ^{[16
,17
]}

Rule, Simon ^{[18
]}

Sun, Steven ^{[19
]}

Phelps, Charles ^{[19
]}

Mahler, Michelle ^{[19
]}

Salman, Mariya ^{[19
]}

Schaffer, Michael ^{[20
]}

Balasubramanian, Sriram ^{[20
]}

Howes, Angela ^{[21
]}

Hallek, Michael ^{[22
,23
]}

机构：

[1] Univ Cologne, Dept Internal Med 1, D-50931 Cologne, Germany

[2] Mayo Clin, Div Hematol, Jacksonville, FL 32224 USA

[3] McMaster Univ, Juravinski Canc Ctr, Hamilton, ON, Canada

[4] Dokuz Eylul Univ, Div Hematol, Izmir, Turkey

[5] IEP Sao Lucas, Hemomed Oncol & Hematol, Sao Paulo, Brazil

[6] Cherkassy Reg Oncol Ctr, Dept Hematol, Cherkassy, Ukraine

[7] Silesian Med Univ Katowice, SPZOZ Zespol Szpitali Miejskich, Chorzow, Poland

[8] Silesian Med Univ, Katowice, Poland

[9] Univ Hosp Leuven, Leuven, Belgium

[10] Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA

[11] Masaryk Univ, Univ Hosp Brno, Dept Internal Med Hematol & Oncol, Brno, Czech Republic

[12] Masaryk Univ, Fac Med, Brno, Czech Republic

[13] Hop Haut Leveque, Pessac, France

[14] Hosp Univ Princesa, IIS IP, Serv Hematol, Madrid, Spain

[15] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO USA

[16] Chaim Sheba Med Ctr, Div Hematol, IL-52621 Tel Hashomer, Israel

[17] Chaim Sheba Med Ctr, Bone Marrow Transplantat, IL-52621 Tel Hashomer, Israel

[18] Derriford Hosp, Dept Haematol, Plymouth PL6 8DH, Devon, England

[19] Janssen Res & Dev, Raritan, NJ USA

[20] Janssen Res & Dev, Spring House, PA USA

[21] Janssen Res & Dev, High Wycombe, Bucks, England

[22] Univ Hosp, Dept Internal Med, Cologne, Germany

[23] Univ Hosp, Ctr Integrated Oncol Cologne Bonn, Cologne, Germany

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[1] Ibrutinib combined with bendamustine/rituximab (BR) in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): safety analysis in the HELIOS trial
Cramer, Paula
Chanan-Khan, Asher
Fraser, Graeme
Demirkan, Fatih
Silva, Rodrigo Santucci
Pylypenko, Halyna
Grosicki, Sebastian
Janssens, Ann
Pristupa, Aleksander
Goy, Andre
Mayer, Jiri
Dilhuydy, Marie-Sarah
Loscertales, Javier
Barlett, Nancy
Avigdor, Abraham
Rule, Simon
Sun, Steven
Phelps, Charles
Mahler, Michelle
Salman, Masha
Howes, Angela
Hallek, Michael
LEUKEMIA & LYMPHOMA, 2015, 56 : 93 - 94
[2] Ibrutinib (I) plus bendamustine and rituximab (BR) in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): a 2-year follow-up of the HELIOS study
Cramer, P.
Fraser, G.
Chanan-Khan, A.
Demirkan, F.
Silva, Santucci R.
Pylypenko, H.
Grosicki, S.
Janssens, A.
Pristupa, A.
Mayer, J.
Dilhuydy, M. -S
Loscertales, J.
Goy, A.
Avigdor, A.
Rule, S.
Phelps, C.
Mahler, M.
Salman, M.
Howes, A.
Balasubramanian, S.
Hallek, M.
ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 34 - 35
[3] Comparing Single-Agent Ibrutinib, Bendamustine Plus Rituximab (BR) and Ibrutinib Plus BR in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): An Indirect Comparison of the RESONATE and HELIOS Trials
Hillmen, Peter
Fraser, Graeme
Jones, Jeffrey
Rule, Simon
O'Brien, Susan
Dilhuydy, Marie Sarah
Jaeger, Ulrich
Grosicki, Sebastian
Cymbalista, Florence
Sun, Steven
Ninomoto, Joi
Mahler, Michelle
Cheng, Mei
Diels, Joris
Clow, Fong
Salman, Mariya
James, Danelle F.
Howes, Angela
Chanan-Khan, Asher
BLOOD, 2015, 126 (23)
[4] Ibrutinib combined with bendamustine/rituximab (BR) in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): subgroup efficacy analyses from the HELIOS trial
Fraser, Graeme
Chanan-Khan, Asher
Cramer, Paula
Demirkan, Fatih
Silva, Rodrigo Santucci
Pylypenko, Halyna
Grosicki, Sebastian
Janssens, Ann
Pristupa, Aleksander
Goy, Andre
Mayer, Jiri
Dilhuydy, Marie-Sarah
Loscertales, Javier
Bartlett, Nancy
Avigdor, Abraham
Rule, Simon
Sun, Steven
Phelps, Charles
Mahler, Michelle
Salman, Masha
Howes, Angela
Hallek, Michael
LEUKEMIA & LYMPHOMA, 2015, 56 : 98 - 100
[5] IBRUTINIB PLUS BENDAMUSTINE AND RITUXIMAB IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL): 2-YEAR FOLLOW-UP INCLUDING MRD FROM THE HELIOS STUDY
Fraser, G.
Cramer, P.
Demirkan, F.
Santucci Silva, R.
Grosicki, S.
Janssens, A.
Mayer, J.
Dilhuydy, M. S.
Pylypenko, H.
Loscertales, J.
Goy, A.
Avigdor, A.
Rule, S.
Phelps, C.
Mahler, M.
Salman, M.
Howes, A.
Hallek, M.
HAEMATOLOGICA, 2016, 101 : 150 - 151
[6] Ibrutinib (I) plus bendamustine and rituximab (BR) in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): a 2-year follow-up of the HELIOS study.
Fraser, Graeme
Cramer, Paula
Demirkan, Fatih
Silva, Rodrigo Santucci
Pylypenko, Halyna
Grosicki, Sebastian
Janssens, Ann
Pristupa, Aleksander
Mayer, Jiri
Dilhuydy, Marie-Sarah
Loscertales, Javier
Goy, Andre
Avigdor, Abraham
Rule, Simon
Phelps, Charles
Mahler, Michelle
Salman, Mariya
Howes, Angela J.
Balasubramanian, Sriram
Chanan-Khan, Asher Alban Akmal
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[7] Three-year follow-up of patients with previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) receiving ibrutinib plus bendamustine and rituximab (BR) versus placebo plus BR: an update of the HELIOS study
Hallek, Michael
Fraser, Graeme
Cramer, Paula
Demirkan, Fatih
Silva, Rodrigo Santucci
Grosicki, Sebastian
Janssens, Ann
Pristupa, Aleksander
Mayer, Jiri
Dilhuydy, Marie Sarah
Loscertales, Javier
Bartlett, Nancy
Avigdor, Abraham
Rule, Simon
Sun, Steven
Mahler, Michelle
Phelps, Charles
Salman, Mariya
Howes, Angela
Chanan-Khan, Asher
LEUKEMIA & LYMPHOMA, 2017, 58 : 192 - 194
[8] Ibrutinib combined with bendamustine/rituximab (BR) in previously treated small lymphocytic lymphoma (SLL): analysis of patients in the HELIOS trial
Chanan-Khan, Asher
Fraser, Graeme
Cramer, Paula
Demirkan, Fatih
Silva, Rodrigo Santucci
Pylypenko, Halyna
Grosicki, Sebastian
Janssens, Ann
Pristupa, Aleksander
Goy, Andre
Mayer, Jiri
Dilhuydy, Marie-Sarah
Loscertales, Javier
Bartlett, Nancy
Avigdor, Abraham
Rule, Simon
Sun, Steven
Phelps, Charles
Mahler, Michelle
Salman, Masha
Howes, Angela
Hallek, Michael
LEUKEMIA & LYMPHOMA, 2015, 56 : 92 - 93
[9] Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study
Chanan-Khan, Asher
Cramer, Paula
Demirkan, Fatih
Fraser, Graeme
Silva, Rodrigo Santucci
Grosicki, Sebastian
Pristupa, Aleksander
Janssens, Ann
Mayer, Jiri
Bartlett, Nancy L.
Dilhuydy, Marie-Sarah
Pylypenko, Halyna
Loscertales, Javier
Avigdor, Abraham
Rule, Simon
Villa, Diego
Samoilova, Olga
Panagiotidis, Panagiots
Goy, Andre
Mato, Anthony
Pavlovsky, Miguel A.
Karlsson, Claes
Mahler, Michelle
Salman, Mariya
Sun, Steven
Phelps, Charles
Balasubramanian, Sriram
Howes, Angela
Hallek, Michael
Assouline, S.
Bence-Bruckler, I.
Buckstein, R.
Fraser, G.
Larratt, L.
Minuk, L.
Villa, D.
Angevine, A.
Bartlett, N.
Bixby, D.
Caimi, P.
Chanan-Khan, A.
Craig, M.
Forero-Torres, A.
Ganguly, S.
Goy, A.
Heffner, L.
Hermann, R.
Lansigan, F.
Leis, J.
Letzer, J.
LANCET ONCOLOGY, 2016, 17 (02): : 200 - 211
[10] Sequoia: Results of a randomized phase iii trial of zanubrutinib versus bendamustine plus rituximab (br) in patients with previously untreated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
Greil, R.
Robak, T.
Giannopoulos, K.
Jurczak, W.
Simkovic, M.
Shadman, M.
Oesterborg, A.
Laurenti, L.
Walker, P.
Opat, S.
Chan, H.
Ciepluch, H.
Tani, M.
Trneny, M.
Brander, D. M.
Flinn, I. W.
Grosicki, S.
Verner, E.
Brown, J. R.
Kahl, B. S.
Ghia, P.
Li, J.
Tian, T.
Zhou, L.
Marimpietri, C.
Paik, J. C.
Cohen, A.
Hillmen, P.
Tam, C. S.
ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 117 - 118

← 1 2 3 4 5 →